Don't get left behind! The modernized is coming. Check it out now.
Say goodbye to!
The new site is coming soon - go to the modernized
Working… Menu

Development of Novel Clinical Endpoints in Intermediate AMD (MACUSTAR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03349801
Recruitment Status : Active, not recruiting
First Posted : November 22, 2017
Last Update Posted : May 24, 2022
Moorfields Eye Hospital NHS Foundation Trust
Novartis Pharmaceuticals
Association for Innovation and Biomedical Research on Light and Image
City, University of London
European Clinical Research Infrastructure Network
La Fondation Voir et Entendre
Hoffmann-La Roche
Radboud University Medical Center
University of Sheffield
University College, London
Carl Zeiss Meditec AG
Innovative Medicines Initiative
Information provided by (Responsible Party):
Frank G. Holz, University Hospital, Bonn

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : November 30, 2022
Estimated Study Completion Date : November 30, 2022
Publications automatically indexed to this study by Identifier (NCT Number):